Effectiveness of complete diagnostic examination in clinical practice settings

Cancer Detection and Prevention

Volumn 30, Issue 6, 2006, Pages 545-551

  Jimbo, Masahito ^a   Meyer, Birgit ^b   Hyslop, Terry ^c   Cocroft, James ^d   Turner, Barbara J ^e   Weinberg, David S ^f   Myers, Ronald E ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

Abnormal findings; Cancer screening; Chart audit; Colorectal neoplasm; Complete diagnostic evaluation; Diagnosis; Fecal occult blood test; Follow up studies; Mass screening; Occult blood

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL EXAMINATION; CLINICAL PRACTICE; COLORECTAL TUMOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; BARIUM SULFATE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCULT BLOOD; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; SIGMOIDOSCOPY;

EID: 37849188152     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.10.001     Document Type: Article

References (18)

1. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 55 1 (2005) 31-44
2. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31.
3. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328 (1993) 1365-1371
4. Kronborg O., Fenger C., Olsen J., Jorgenson O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with fecal occult blood test. Lancet 348 (1996) 1467-1471
5. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of fecal occult blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
6. Lurie J.D., and Welch H.G. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst 91 (1999) 1641-1646
7. Myers R.E., Turner B., Weinberg D., Hyslop T., Hauck W.W., Brigham T., et al. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 38 (2004) 375-381
8. Levin B., Hess K., and Johnson C. Colorectal cancer screening in the community: adequacy of follow-up is related to physician specialty. Gastroenterology 110 (1996) A550
9. Myers R.E., Balshem A.M., Wolf T.A., Ross E.A., and Millner L. Screening for colorectal neoplasia: physician's adherence to complete diagnostic evaluation. Am J Public Health 83 (1993) 1620-1622
10. Shields H.M., Weiner M.S., Henry D.R., Lloyd J.A., Ransil B.J., Lamphier D.A., et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am J Gastroenterol 96 (2001) 196-203
11. Morris J.B., Stellato T.A., Guy B.B., Gordon N.H., and Berger N.A. A critical analysis of the largest reported mass fecal occult blood screening program in the United States. Am J Surg 161 1 (1991) 101-106
12. Myers R.E., Turner B., Weinberg D., Hauck W.W., Hyslop T., Brigham T., et al. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings. Prev Med 33 (2001) 249-260
13. Myers R.E., Fishbein G., Hyslop T., Hauck W.W., Kutch M., Grana J.R., et al. Measuring complete diagnostic evaluation in colorectal cancer screening. Cancer Detect Prev 25 2 (2001) 174-182
14. Ragunathan TE, Solenberger PW, Van Hoewyk J. IVEware: Imputation and Variance Estimation Software-User Guide. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2002.
15. Baig N., Myers R.E., Turner B.J., Grana J., Rothermel T., Schlackman N., et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 98 9 (2003) 2078-2081
16. Sharma V.K., Vasudeva R., and Howden C.W. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am J Gastroenterol 95 6 (2000) 1551-1556
17. Nadel M.R., Shapiro J.A., Klabunde C.N., Seef L.C., Uhler R., Smith R.A., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 142 2 (2005) 86-94
18. Lieberman D.A., and Weiss D.G. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345 8 (2001) 555-560